BeStock  
Stocks › Biotechnology › TVTX

Travere Therapeutic TVTX

US equityMarket cap rank #2128Biotechnology
$47.00 −$1.30 (-2.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $47.29 +0.62%
Open$48.09
Prev close$48.30
Day range$46.90 – $49.35
Volume1.33M
Market cap$4.51B
P/E (TTM)–
Dividend yield–

TVTX Stock News

Headlines matching Travere Therapeutic or the TVTX ticker, most recent first.

  • Guggenheim Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $89 PositiveMarket news · 24 Sep 2026 · Direct mention
  • BofA Securities Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $71Market news · 24 Sep 2026 · Direct mention
  • Wedbush Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $76 PositiveMarket news · 22 Sep 2026 · Direct mention
  • Travere Therapeutics: Eric Dube, Ph.D., to Step Down as Pres and CEO in Dec TVTXDow Jones · 22 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $70 to $90Market news · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $90 PositiveMarket news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $68 to $85Market news · 6 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $62 to $85Market news · 5 Aug 2026 · Direct mention
  • Piper Sandler Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $68 PositiveMarket news · 17 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)TipRanks · 12 Aug 2026 · Direct mention
  • CCORF Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $70Market news · 12 Aug 2026 · Direct mention
  • Evercore Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $78 PositiveMarket news · 10 Aug 2026 · Direct mention
  • Stifel Maintains Travere Therapeutic(TVTX.US) With Hold Rating, Maintains Target Price $62Market news · 10 Aug 2026 · Direct mention
  • CCORF Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $62 PositiveMarket news · 30 Jul 2026 · Direct mention
  • TD Cowen Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $60Market news · 22 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TVTX.

Sign in to join the discussion.

Scroll to Top